Shandong Buchang Pharmaceuticals Co Ltd Total Liabilities
Shandong Buchang Pharmaceuticals Co Ltd total liabilities. Based on the latest financial reports, Shandong Buchang Pharmaceuticals Co Ltd (603858) has total liabilities worth CN¥9.50 Billion CNY (≈ $1.39 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Shandong Buchang Pharmaceuticals Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Total liabilities of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. This chart illustrates how Shandong Buchang Pharmaceuticals Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Shandong Buchang Pharmaceuticals Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Buchang Pharmaceuticals Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Civitas Resources Inc
NYSE:CIVI
|
USA | $8.43 Billion |
|
Mister Car Wash, Inc. Common Stock
NASDAQ:MCW
|
USA | $2.03 Billion |
|
Huada Automotive Tech Corp Ltd
SHG:603358
|
China | CN¥3.90 Billion |
|
SHAND.GOLD MNG LTD H HD 1
F:188H
|
Germany | €110.94 Billion |
|
Pertamina Geothermal Energy
JK:PGEO
|
Indonesia | Rp952.10 Million |
|
Shake Shack Inc
NYSE:SHAK
|
USA | $1.36 Billion |
|
Shufersal
TA:SAE
|
Israel | ILA10.24 Billion |
|
China Suntien Green Energy Corp Ltd
SHG:600956
|
China | CN¥58.87 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Shandong Buchang Pharmaceuticals Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Shandong Buchang Pharmaceuticals Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Shandong Buchang Pharmaceuticals Co Ltd Total Liabilities Ratios Explained
Shandong Buchang Pharmaceuticals Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Buchang Pharmaceuticals Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below shows the annual total liabilities of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥9.52 Billion ≈ $1.39 Billion |
+0.04% |
| 2023-12-31 | CN¥9.52 Billion ≈ $1.39 Billion |
-1.66% |
| 2022-12-31 | CN¥9.68 Billion ≈ $1.42 Billion |
+1.48% |
| 2021-12-31 | CN¥9.54 Billion ≈ $1.40 Billion |
+5.07% |
| 2020-12-31 | CN¥9.08 Billion ≈ $1.33 Billion |
+22.69% |
| 2019-12-31 | CN¥7.40 Billion ≈ $1.08 Billion |
+19.97% |
| 2018-12-31 | CN¥6.17 Billion ≈ $902.29 Million |
+3.15% |
| 2017-12-31 | CN¥5.98 Billion ≈ $874.77 Million |
+0.30% |
| 2016-12-31 | CN¥5.96 Billion ≈ $872.16 Million |
-29.91% |
| 2015-12-31 | CN¥8.50 Billion ≈ $1.24 Billion |
+82.70% |
| 2014-12-31 | CN¥4.65 Billion ≈ $681.06 Million |
+75.26% |
| 2013-12-31 | CN¥2.66 Billion ≈ $388.60 Million |
+61.33% |
| 2012-12-31 | CN¥1.65 Billion ≈ $240.87 Million |
+0.36% |
| 2011-12-31 | CN¥1.64 Billion ≈ $240.00 Million |
-- |
About Shandong Buchang Pharmaceuticals Co Ltd
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.